, 1 % sodium pyruvate, 1 % non-essential amino acids (Nissui Pharmaceutical Co., Tokyo), 100IU/ml penicillin G, 100,ug/ml streptomycin, and 250,ug/ml amphotericin B under 5% C02-95% air at 37 C.
II. Mitogen-induced calcium response T98G cells in the exponential growth phase were subcultured on a glass coverslip in a 35-mm diameter culture dish at 2.5 X 103 cells/ml in culture medium under 5% C02-95% air at 37°C. Cells on a coverslip were washed three times with DMEM and then serum-starved for 6 hours by incubating with culture medium lacking FBS. The cells were loaded with 2.5 ,uM fura-2/acetoxymethyl ester (Dojin Chemical Co., Tokyo) in serum-free DMEM containing 5% bovine serum albumin (fraction V; Miles Inc., Kankakee, Ill., U.S.A.) at 37 C for 30 minutes and washed three times with Hank's balanced salt solu tion without phenol red (HBSS) (Nissui Phar maceutical Co.). The cells attached to the coverslip were placed in a bath (volume 0.5 ml) on the stage of a fluorescence microscope (Optiphoto; Nikon, Tokyo) equipped with a photomultiplier tube (R649; Hamamatsu Electronics, Shizuoka), a photon counter (545A; NF, Hiroshima), and an appropriate combination of filters (Nihon Shinkuu Kougaku, Osaka). Alternating excitation was repeated with wavelengths of 340 (F340) and 380 nm (F380). Ratio values (F340/F380) were converted to cytosolic free calcium concentration ([Ca 2+]i) by a calibration curve based on the fluorescence of acid-free fura-2 solution. 15) As previously reported, the ratio of F340/ F380 was linear with log[Ca2+]i over a wide range of 80-1000 nM.31" [Ca 21]i was calculated using a per sonal computer. HBSS at 37'C was continuously cir culated at 1 ml/min. Cells on the coverslip were ex posed to the various concentrations of recombinant human PDGF (R&D Systems Inc., Minneapolis, Minn., U.S.A.) or EGF (Higeta Shoyu Co., Chiba), FBS, or inhibitors at 37 C using circulation medium (HBSS) containing each agent as follows. All ex periments were performed in triplicate.
PDGF-induced calcium response was examined by stimulating cells with 10 ng/ml PDGF. Extracellular calcium was then removed by circulating HBSS with 2.26 mM ethylene glycol bis(l-aminoethyl ether) N,N,N,N-tetraacetic acid (EGTA) (Dojin Chemical Co.), and cells were stimulated with 10 ng/ml PDGF. Cells were pretreated with 10,uM nicardipine (Yamanouchi Pharmaceutical Co., Tokyo) for 6 hours in serum-free DMEM in the C02 incubator at 37'C, and then stimulated by 10 ng/ml PDGF. After stimulation by PDGF, the circulating medium was changed to HBSS containing 10% FBS as a positive control.
The effects of trapidil and suramin on PDGF-in duced calcium response were examined by pretreat ment of cells for 5 minutes with 10 or 100 pg/ml trapidil (Mochida Pharmaceutical Co., Tokyo), or 10 or 100,ug/ml suramin (Bayer AG, Wuppertal Elberfeld, Germany). The cells were then stimulated by 10 ng/ml PDGF or 10% FBS in the HBSS circula tion medium containing the same concentration of trapidil or suramin.
The effects of trapidil and suramin on EGF-in duced calcium response were studied by pretreat ment of cells for 5 minutes with 10 or 100,ug/ml trapidil, or 10 or 100,u/ml suramin, followed by stimulation by 100 ng/ml EGF or 10% FBS in HBSS circulation medium containing the same concentra tion of trapidil or suramin.
III.
Protein tyrosine phosphorylation T98G cells were cultured at 60-80% confluence in 35-mm-diameter culture dishes, then the medium was replaced with serum-free DMEM. After serum starvation for 16 hours in the absence or presence of trapidil or suramin, cells were treated with 10 ng/ml PDGF or 100 ng/ml EGF. The stimulation was ter minated at various times by immediately aspirating the medium and adding a previously boiled elec trophoresis sample buffer (100,u1/plate) consisting of 5 mM potassium phosphate (pH 6.8), 2% sodium dodecyl sulfate (SDS), 10 mM dithiothreitol, 5% 2 mercaptoethanol, 0.04% bromophenol blue, and 2% glycerol. Cell lysates were collected with a rubber policeman, transferred to microcentrifuge tubes, then boiled for 2 minutes. The lysates were passed through a 22-gauge needle several times and then a 27-gauge needle 20 times. (Fig. 4, lanes 2 and 3) , and probably represents the receptor for PDGF. Pretreat ment of the cells with trapidil for 16 hours inhibited the PDGF-induced tyrosine phosphorylation of this protein (Fig. 4, lanes 4 and 5) . Suramin also com pletely inhibited the PDGF-induced phosphorylation of the 185 kd protein (Fig. 4, lanes 6 and 7) . In addi tion, a protein with molecular mass of 130 kd, which already contained phosphotyrosine before addition of PDGF and was not modified with PDGF (Fig. 4,  lanes 1-3) , showed tyrosine-dephosphorylation with both trapidil and suramin treatment (Fig. 4, lanes 4  7) .
EGF induced rapid tyrosine phosphorylation of the 170 kd protein supposed to be the receptor for EGF and increased the modification of a 76 kd pro tein (Fig. 5, lanes 2-4) , which was weakly tyrosine phosphorylated before addition of EGF (lane 1).
Pretreatment of cells with trapidil only partially in hibited the EGF-induced
tyrosine phosphorylation of 170 and 76 kd proteins (Fig. 5, lanes 5 and 6) . This was also the case with suramin (Fig. 5, lanes 7 and 8) . The phosphorylation of 170 and 76 kd proteins was only partially decreased with 100 and 200 ug/ml suramin, which completely inhibited the EGF-in duced calcium response (Fig. 3) . PDGF-induced calcium response and tyrosine phosphorylation were significantly inhibited in the presence of trapidil or Our study confirms that trapidil and suramin may be clinically useful as an anti-cancer agents, and also suggests that these agents may be useful to study the biochemical signal events leading to proliferation of glioma cells in vitro. 
